{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:36:04Z","timestamp":1794062164065,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23\\u202FK14855"],"award-info":[{"award-number":["23\\u202FK14855"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.radonc.2026.111752","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:56:01Z","timestamp":1787925361000},"page":"111752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1\/JGOG1088S)"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-6472","authenticated-orcid":false,"given":"Keisuke","family":"Tsuchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-0228","authenticated-orcid":false,"given":"Takafumi","family":"Toita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ikushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-4717","authenticated-orcid":false,"given":"Taichi","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-630X","authenticated-orcid":false,"given":"Shin","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Murotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Okuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4606-5662","authenticated-orcid":false,"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-238X","authenticated-orcid":false,"given":"Tetsuo","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-1731","authenticated-orcid":false,"given":"Haruya","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ishidera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5241-290X","authenticated-orcid":false,"given":"Chisato","family":"Tonoiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetaka","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikou","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-3144","authenticated-orcid":false,"given":"Tatsuya","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111752_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2026.111752_b0010","unstructured":"National Comprehensive Cancer Network. Cervical cancer (version 1.2023). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf; 2023 [accessed 18 February 2023]."},{"key":"10.1016\/j.radonc.2026.111752_b0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111752_b0020","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111752_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(23)02405-4","article-title":"Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial","volume":"403","author":"Oaknin","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111752_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2024.10.023","article-title":"Standard of care treatment for stage IVB cervical cancer: a systematic review and meta-analysis","volume":"191","author":"Hunsberger","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jamaoncol.2018.2677","article-title":"Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2019.10.033","article-title":"Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: a novel treatment strategy","volume":"156","author":"Perkins","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.radonc.2026.111752_b0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4143\/crt.2013.45.3.193","article-title":"Impact of chemoradiation on prognosis in stage IVB cervical cancer with distant lymphatic metastasis","volume":"45","author":"Kim","year":"2013","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2026.111752_b0055","first-page":"3471","article-title":"Prognostic factors and treatment outcome for patients with stage IVB cervical cancer","volume":"36","author":"Oishi","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2026.111752_b0060","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.21037\/tcr.2019.07.21","article-title":"Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis","volume":"8","author":"Li","year":"2019","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.radonc.2026.111752_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13014-019-1297-x","article-title":"Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer","volume":"14","author":"Yin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0070","article-title":"Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab - an exploratory study","volume":"23","author":"Wiley","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.radonc.2026.111752_b0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ygyno.2022.04.013","article-title":"Local treatment improves survival in patients with stage IVB cervical cancer","volume":"165","author":"Xu","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ijgo.70077","article-title":"The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer","volume":"170","author":"Miyoshi","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.radonc.2026.111752_b0085","article-title":"Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study","volume":"36","author":"Zhou","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2026.111752_b0090","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2020.31.e8","article-title":"Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study","volume":"31","author":"Li","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.radonc.2026.111752_b0095","article-title":"Role of locoregional surgery in treating FIGO 2009 stage IVB cervical cancer patients: a population-based study","volume":"11","author":"Wang","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2026.111752_b0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ijgo.15121","article-title":"Local treatment strategies in stage IVB cervical squamous cell carcinoma and adenocarcinoma","volume":"164","author":"Xu","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.radonc.2026.111752_b0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijrobp.2023.07.046","article-title":"Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies","volume":"118","author":"Laville","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111752_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/jog.70119","article-title":"Efficacy and safety of concurrent chemoradiotherapy as first-line treatment for stage IVB cervical cancer: a single-center retrospective observational study","volume":"51","author":"Ishidera","year":"2025","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.radonc.2026.111752_b0115","doi-asserted-by":"crossref","unstructured":"Tanigawa T, Takeshima N, Ishikawa H, Nishio S, Usami T, Yamawaki T, et al. Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: an open-label multicenter phase II trial (JGOG1079). Gynecol Oncol 2022Jun;165(3):413-9. https:\/\/doi.org\/10.1016\/j.ygyno.2022.04.011.","DOI":"10.1016\/j.ygyno.2022.04.011"},{"key":"10.1016\/j.radonc.2026.111752_b0120","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ccr3.3955","article-title":"Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: a dose-volume analysis","volume":"9","author":"Tomizawa","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.radonc.2026.111752_b0125","article-title":"The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review","volume":"19","author":"Ollivier","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2026.111752_b0130","doi-asserted-by":"crossref","unstructured":"Nakashima T, Matsumoto K, Yoshitake T, Kunitake N, Abe M, Ariyoshi K, et al. Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study. Jpn J Radiol 2025 Dec 24;[Epub ahead of print]. https:\/\/doi.org\/10.1007\/s11604-025-01923-1.","DOI":"10.1007\/s11604-025-01923-1"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:08:03Z","timestamp":1791806883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026005918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S0167814026005918"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111752","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1\/JGOG1088S)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111752"}}